These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21215698)

  • 41. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
    Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
    Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
    Edmonston DL; South AM; Sparks MA; Cohen JB
    Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
    Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ACE and ACE2 in inflammation: a tale of two enzymes.
    Gaddam RR; Chambers S; Bhatia M
    Inflamm Allergy Drug Targets; 2014; 13(4):224-34. PubMed ID: 25019157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver fibrosis: a balance of ACEs?
    Warner FJ; Lubel JS; McCaughan GW; Angus PW
    Clin Sci (Lond); 2007 Aug; 113(3):109-18. PubMed ID: 17600527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-converting enzyme 2: central regulator for cardiovascular function.
    Xia H; Lazartigues E
    Curr Hypertens Rep; 2010 Jun; 12(3):170-5. PubMed ID: 20424953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury.
    Yang G; Chu PL; Rump LC; Le TH; Stegbauer J
    Antioxid Redox Signal; 2017 Apr; 26(12):645-659. PubMed ID: 27889958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension.
    Zhang J; Dong J; Martin M; He M; Gongol B; Marin TL; Chen L; Shi X; Yin Y; Shang F; Wu Y; Huang HY; Zhang J; Zhang Y; Kang J; Moya EA; Huang HD; Powell FL; Chen Z; Thistlethwaite PA; Yuan ZY; Shyy JY
    Am J Respir Crit Care Med; 2018 Aug; 198(4):509-520. PubMed ID: 29570986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation.
    Chappell MC
    Arthritis Res Ther; 2010; 12(3):128. PubMed ID: 20602809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
    Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
    Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.
    Cole-Jeffrey CT; Liu M; Katovich MJ; Raizada MK; Shenoy V
    J Cardiovasc Pharmacol; 2015 Dec; 66(6):540-50. PubMed ID: 26322922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.
    Garabelli PJ; Modrall JG; Penninger JM; Ferrario CM; Chappell MC
    Exp Physiol; 2008 May; 93(5):613-21. PubMed ID: 18356559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
    Osterreicher CH; Taura K; De Minicis S; Seki E; Penz-Osterreicher M; Kodama Y; Kluwe J; Schuster M; Oudit GY; Penninger JM; Brenner DA
    Hepatology; 2009 Sep; 50(3):929-38. PubMed ID: 19650157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ACE2, a new regulator of the renin-angiotensin system.
    Burrell LM; Johnston CI; Tikellis C; Cooper ME
    Trends Endocrinol Metab; 2004; 15(4):166-9. PubMed ID: 15109615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
    Dzau VJ
    Basic Res Cardiol; 1993; 88 Suppl 1():1-14. PubMed ID: 8395169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.
    Li Y; Zeng Z; Li Y; Huang W; Zhou M; Zhang X; Jiang W
    Shock; 2015 Apr; 43(4):395-404. PubMed ID: 25768373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ACE2: a new target for cardiovascular disease therapeutics.
    Raizada MK; Ferreira AJ
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications.
    Chatterjee P; Gheblawi M; Wang K; Vu J; Kondaiah P; Oudit GY
    Clin Sci (Lond); 2020 Sep; 134(17):2319-2336. PubMed ID: 32901821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACE2: more of Ang-(1-7) or less Ang II?
    Ferrario CM
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):1-6. PubMed ID: 21045683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.